# Attain Performa(TM) Quadripolar Lead Study

Study · id `cardio:ct-nct01751022` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01751022](<https://clinicaltrials.gov/study/NCT01751022>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01751022

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1202 participants.

## Technical summary

Registry record NCT01751022. Allocation not applicable; no masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2015-02 (actual). Results posted on 2016-12-05.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1202 participants (enrolled count; ClinicalTrials.gov record NCT01751022, source copy `cardio:ctgov-nct01751022-2016-12-05`, retrieved 2026-10-26)
- Start date: 2012-12 (registry gives no type) (ClinicalTrials.gov record NCT01751022, source copy `cardio:ctgov-nct01751022-2016-12-05`, retrieved 2026-10-26)
- Primary completion: 2015-02 (actual) (ClinicalTrials.gov record NCT01751022, source copy `cardio:ctgov-nct01751022-2016-12-05`, retrieved 2026-10-26)
- Completion: 2015-02 (actual) (ClinicalTrials.gov record NCT01751022, source copy `cardio:ctgov-nct01751022-2016-12-05`, retrieved 2026-10-26)
- Results first posted: 2016-12-05 (ClinicalTrials.gov record NCT01751022, source copy `cardio:ctgov-nct01751022-2016-12-05`, retrieved 2026-10-26)
- Countries: United States; Australia; Austria; Belgium; Canada; Chile; Denmark; Finland; France; Germany; Greece; Hungary; India; Israel; Italy; Malaysia; Netherlands; Norway; Romania; Saudi Arabia; Serbia; Slovakia; Slovenia; South Africa; Spain; Switzerland; United Kingdom (ClinicalTrials.gov record NCT01751022, source copy `cardio:ctgov-nct01751022-2016-12-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01751022-2016-12-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Attain Performa(TM) Quadripolar Lead Study
- Condition: Heart Failure
- Intervention (Device): Device: Attain Performa Pacing Lead (along with a standard CRT-D system)
- Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Medtronic Cardiac Rhythm and Heart Failure (`cardio:org-medtronic-cardiac-rhythm-and-heart-failure`)

## Provenance

Content hash: 9839839d5d59903d42c12627a0a996ab0dab179c758147f92b22280253ea4ada
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
